Health Economics & Outcomes Research
We generate robust, real‑world evidence on the value of healthcare to inform decisions that improve patient outcomes and maximise the efficient use of resources.
Our Mission
We aim to inform healthcare decisions that improve patient outcomes while optimising the use of limited resources in the UK and internationally, by combining economic evaluation, real‑world data, and outcomes research.
Core Methodological Pillars
- Economic Evaluation: Assessing the cost‑effectiveness of healthcare interventions using decision‑analytic models informed by real‑world data.
- Real‑World Evidence (RWE): Analysing observational and routinely collected data, including datasets mapped to the Common Data Model, to evaluate effectiveness in practice.
- Outcomes Research: Measuring clinical outcomes, quality of life, and patient‑reported outcomes to understand impact on patients and carers.

Application Domains
We apply our methods across many different healthcare conditions and interventions, with particular expertise in musculoskeletal health:
- Osteoporosis & Fracture Prevention: Risk assessment, prevention strategies, and evaluation of services such as fracture liaison programmes.
- Osteoarthritis: Long‑term evaluation of medical and surgical care, including patient‑reported outcomes and decision‑support tools.
- Rare Diseases: Assessing clinical, quality‑of‑life, and economic impact of rare musculoskeletal conditions on patients and healthcare systems.
Data
Our research is grounded in large‑scale real‑world datasets that reflect routine clinical practice, including:
- Electronic health records (e.g. HES, CPRD, SIDIAP)
- Common Data Models (e.g. OMOP)
- National and international registries (e.g. NJR, Geneva Arthroplasty Registry)
- Observational cohorts and disease studies (RUDY)
- Clinical trial data with long‑term follow‑up
Collaborations, Partnerships and Funding
We collaborate with academic institutions, healthcare providers, policymakers, charities, and industry partners.
Our work is supported by organisations such as NIHR, the European Commission, the International Osteoporosis Foundation, and patient charities. Patient and Public Involvement is central to our research, ensuring it remains patient‑centred and grounded in lived experience.
Our team
-
Rafael Pinedo Villanueva
Associate Professor
-
Gianluca Fabiano
Senior Researcher in Health Economics
-
Ian Koblbauer
Senior Researcher in Health Economics
-
Beata Giglio
Programme Manager for Functional Genomics Cluster / Project Manager for Health Economics and Outcomes Research Group
-
Karen Facey
Scientific Adviser in HTA
Collaborators
International groups
Projects
CO-ACTION
Multidisciplinary collaborative research project focused on helping people with multiple long-term conditions stay well. This project’s principal investigators are based at the University of Southampton’s Research group on Long Term Conditions.
DEdiCADE
How did patients like me do? A patient-centred tool (DEdiCADE) to support decision-making and long-term follow-up in elective total hip arthroplasty
Epidemiology and burden of imminent subsequent fractures in postmenopausal women
A Distributed Network Analysis using data from six European countries mapped to OMOP Common Data Model
FAME
The Fractured Ankle Management Evaluation
FRUITI
World Hip Trauma Evaluation - FRUITI: Fix or Replace Undisplaced Intracapsular fractures Trial of Interventions
STAR
Support and Treatment After Replacement
UTMoSt
Risk-benefit and costs of unicompartmental (compared to total) knee replacement for patients with multiple co-morbidities: a non-randomised study, and different novel approaches to minimise confounding.
Validation Study
Validating OMOP-mapped CPRD data for health economic analyses in the UK
Latest news
-
Patients like me
1 November 2022